Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories. Growth in POC testing is being fueled by many factors including the growing number of people with diabetes, the globalization of infectious diseases and the associated public health issues, advances in therapies giving physicians more tools for treatment of patients if the doctor is able to rapidly diagnose the problem, the need to monitor an ever-growing group of people with chronic diseases such as cardiovascular diseases, arthritis, cancer and other chronic conditions, and many other factors.
Point of Care Testing (POCT) is attracting considerable investor and industry activity. This Kalorama Information report, The World Market for Point of Care Diagnostics, the result of primary and secondary research into the point of care diagnostics market, presents the most current analysis of the POC Diagnostics industry and the role it plays in medical practice. This report takes an in depth look at the market, technologies, and trends in decentralized testing, looking at both self-testing by patients (also referred to as the over-the-counter (OTC) market, and at point-of-care testing by healthcare professionals.
As part of this report's coverage, the following data is included:
The field for rapid test devices is crowded. This report profiles 140 companies that currently market POC, plus more than 40 additional companies that are developing POC technologies and products or that have just recently entered this market. Companies profiled in this report are using a wide range of different technologies to develop and market rapid tests for much of the range of in vitro diagnostic (IVD) tests that can be performed in centralized laboratories.
The report offers a quantitative assessment of specific markets, worldwide, in U.S. dollars for 2011 to 2016. Information is provided in order to set the status quo of tests and technologies, and to get a look at what is coming. The report also discusses how these tests will affect the economics of healthcare over the near term and longer when possible.
As part of Kalorama Information's comprehensive coverage of Point of Care Diagnostics the following companies are discussed:
Related Reports:The World Market for Medical Beds
Nov 8, 2013 - KLI5153655 - $3,995.00
The World Market for Immunoassays
Nov 6, 2013 - KLI5146358 - $5,995.00
Reimbursement for IVD Tests
Oct 25, 2013 - KLI5141105 - $1,995.00
The World Market for Infectious Disease Diagnostic Tests
Oct 21, 2013 - KLI5137619 - $3,995.00
The Global Market for Biomarkers (Cancer Markers, Cardiac Markers, Blood Markers, Endocrine Markers, Infectious Disease and Neurological Disease Markers)
Oct 16, 2013 - KLI5136277 - $3,995.00
The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition
Sep 22, 2013 - KLI5123810 - $3,500.00
Laboratory Information Systems (LIS / LIMS): Software, Hardware and Service Markets for Clinical Labs and Drug Discovery Labs
Sep 19, 2013 - KLI5121162 - $4,200.00
The IVD Market in Brazil
Sep 13, 2013 - KLI5116724 - $1,500.00
The World Market for Cloud Computing in Healthcare (Saas, IaaS, PaaS, Other Cloud Markets, Healthcare IT Spending and Other Trends)
Sep 10, 2013 - KLI5114613 - $3,995.00
The World Market for Minimally Invasive Surgical Devices (Cardiovascular, ENT, Neurosurgery, Gastrointestinal, Urological/Gynecological and Other MIS Device Markets)
Aug 21, 2013 - KLI5101545 - $4,500.00
Questions?Contact a research specialist >
Most Popular ResearchThe Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition Results of The 2012 Kalorama IVD Procedure Count: White Paper IVD Market Research Bundle (In Vitro Diagnostic Test Markets, BRIC and Other Regional Markets, Biomarker Testing and Other Pharmacodiagnostics) The World Market for Point of Care (POC) Diagnostics White Paper: Animal Diagnostics: "Sister Market" to IVD? World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)